مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

278
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

139
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

PRIMARY BONE LYMPHOMA: A CLINICOPATHOLOGICAL RETROSPECTIVE STUDY OF 28 PATIENTS IN A SINGLE INSTITUTION (SHORT COMMUNICATION)

Pages

  814-820

Abstract

 BACKGROUND: PRIMARY BONE LYMPHOMA (PBL) is a rare disease and distinct clinicopathological entity. The optimal treatment strategy is still unclear. Because of rarity of PBL, we report our institute experience in PBL clinicopathological feature and treatment results.METHODS: 28 patients diagnosed with PBL were referred to Omid Hospital, cancer research center (CRC), between March 2001 and February 2009. Immunophenotype studies on 16 out of 28 pathological blocks were performed. We analyzed disease free survival (DFS) and overall survival (OS) rates.RESULTS: 14 patients with PBL were analyzed retrospectively.17 patients (60.7%) were male and 11 (39.3%) were female with a median age of 41 years (range: 11-79). Long bones were the most primarily site of involvement (71%).26 (93%) patients had DIFFUSE LARGE B CELL LYMPHOMA and 2 (7%) had small lymphoblastic lymphoma. One (3%) patient received radiation alone, 18 (66%) cases received combined modality (chemotherapy+radiotherapy) and 8 (30%) received only CHEMOTHERAPY during their treatment period. The median follow up was 18 months (range: 1-82). Mean DFS was 51 months (range: 37-66). Overall survival (OS) was 54 months (range: 40-68). OS was significantly better in the chemoradiotherapy group compared with other two groups (64 versus 27 months, respectively, p=0.014). DFS was also significantly better in combined modality arm compared with other two groups (64 versus 21 months, respectively, p=0.003).CONCLUSIONS: In spite of small number of patients reported in this study, combined modality treatment (chemotherapy and RADIOTHERAPY) was shown to be useful as an effective treatment strategy in PBL.

Cites

  • No record.
  • References

  • No record.
  • Cite

    APA: Copy

    GHAVAM NASIRI, MOHAMMAD REZA, VARSHOEE, FATEMEH, MOHTASHAMI, SAMIRA, RAZIEE, HAMID REZA, ALEDAVOOD, AMIR, GHAFARZADEH, KAMRAN, MEMAR, BAHRAM, VOJDANI, SOHEIL, & SARVIZADEH, MOSTAFA. (2011). PRIMARY BONE LYMPHOMA: A CLINICOPATHOLOGICAL RETROSPECTIVE STUDY OF 28 PATIENTS IN A SINGLE INSTITUTION (SHORT COMMUNICATION). JOURNAL OF RESEARCH IN MEDICAL SCIENCES (JRMS), 16(6), 814-820. SID. https://sid.ir/paper/594077/en

    Vancouver: Copy

    GHAVAM NASIRI MOHAMMAD REZA, VARSHOEE FATEMEH, MOHTASHAMI SAMIRA, RAZIEE HAMID REZA, ALEDAVOOD AMIR, GHAFARZADEH KAMRAN, MEMAR BAHRAM, VOJDANI SOHEIL, SARVIZADEH MOSTAFA. PRIMARY BONE LYMPHOMA: A CLINICOPATHOLOGICAL RETROSPECTIVE STUDY OF 28 PATIENTS IN A SINGLE INSTITUTION (SHORT COMMUNICATION). JOURNAL OF RESEARCH IN MEDICAL SCIENCES (JRMS)[Internet]. 2011;16(6):814-820. Available from: https://sid.ir/paper/594077/en

    IEEE: Copy

    MOHAMMAD REZA GHAVAM NASIRI, FATEMEH VARSHOEE, SAMIRA MOHTASHAMI, HAMID REZA RAZIEE, AMIR ALEDAVOOD, KAMRAN GHAFARZADEH, BAHRAM MEMAR, SOHEIL VOJDANI, and MOSTAFA SARVIZADEH, “PRIMARY BONE LYMPHOMA: A CLINICOPATHOLOGICAL RETROSPECTIVE STUDY OF 28 PATIENTS IN A SINGLE INSTITUTION (SHORT COMMUNICATION),” JOURNAL OF RESEARCH IN MEDICAL SCIENCES (JRMS), vol. 16, no. 6, pp. 814–820, 2011, [Online]. Available: https://sid.ir/paper/594077/en

    Related Journal Papers

  • No record.
  • Related Seminar Papers

  • No record.
  • Related Plans

  • No record.
  • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button